GOLBALVO
Live / Allowed — Notice of allowance issued (as of 07 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98641604
- Mark type
- Stylized text
- Filed
- 10 Jul 2024
- Published for opposition
- 12 Aug 2025
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes.
Owner
- Celgene Corporation, Princeton, NJ, US
- Celgene Corporation, Princeton, NJ, US
Prosecution history
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Aug 2025 — PUBLISHED FOR OPPOSITION
- 06 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Jun 2025 — NOTICE OF REVIVAL - E-MAILED
- 10 Jun 2025 — PETITION TO REVIVE-GRANTED
- 10 Jun 2025 — TEAS PETITION TO REVIVE RECEIVED
- 20 May 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 20 May 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 03 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Feb 2025 — NON-FINAL ACTION E-MAILED